TNDM (STOCKS)
Tandem Diabetes Care, Inc.
$16.760000
+0.160000 (+0.96%)
Prev close: $16.600000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- John F. Sheridan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,149.23M
- Employees
- 2,650
- P/E (TTM)
- -11.96
- P/B (TTM)
- 8.59
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.03B |
| Benefits Costs and Expenses | $839.89M |
| Cost Of Revenue | $463.14M |
| Costs And Expenses | $1.12B |
| Gross Profit | $564.40M |
| Operating Expenses | $648.21M |
| Selling, General, and Administrative Expenses | $439.32M |
| Other Operating Expenses | $193.79M |
| Operating Income/Loss | -$83.81M |
| Income/Loss Before Equity Method Investments | -$83.54M |
| Income/Loss From Continuing Operations After Tax | -$94.55M |
| Income/Loss From Continuing Operations Before Tax | $187.64M |
| Income/Loss From Equity Method Investments | -$14.52M |
| Income Tax Expense/Benefit | -$3.51M |
| Net Income/Loss | -$94.55M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$94.55M |
| Net Income/Loss Available To Common Stockholders, Basic | -$94.55M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.40 |
| Diluted Earnings Per Share | -$1.40 |
| Basic Average Shares | 271,113,000 |
| Diluted Average Shares | 271,113,000 |
| Assets | $1.15B |
| Current Assets | $887.10M |
| Inventory | $126.40M |
| Other Current Assets | $760.70M |
| Noncurrent Assets | $266.29M |
| Fixed Assets | $83.25M |
| Other Non-current Assets | $183.04M |
| Liabilities | $1.02B |
| Current Liabilities | $247.96M |
| Accounts Payable | $59.86M |
| Wages | $55.70M |
| Other Current Liabilities | $132.40M |
| Noncurrent Liabilities | $773.03M |
| Commitments and Contingencies | $0.00 |
| Equity | $132.40M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $132.40M |
| Liabilities And Equity | $1.15B |
| Net Cash Flow From Operating Activities | $19.61M |
| Net Cash Flow From Operating Activities, Continuing | $19.61M |
| Net Cash Flow From Investing Activities | -$131.76M |
| Net Cash Flow From Investing Activities, Continuing | -$131.76M |
| Net Cash Flow From Financing Activities | $235.48M |
| Net Cash Flow From Financing Activities, Continuing | $235.48M |
| Exchange Gains/Losses | $2.42M |
| Net Cash Flow | $125.75M |
| Net Cash Flow, Continuing | $123.34M |
| Comprehensive Income/Loss | -$90.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$90.00M |
| Other Comprehensive Income/Loss | -$69.02M |